FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090435 [Registered on: 08/07/2025] Trial Registered Prospectively
Last Modified On: 08/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   Can Homeopathic Medicines Help Reduce Blood Sugar and Uric Acid in People Who Have Both Type 2 Diabetes and High Uric Acid? A Study 
Scientific Title of Study   The effectiveness of homoeopathic medicines in lowering blood glucose and uric acid levels in patient with co-existing type II diabetes mellitus and hyperuricemia - A quasi experimental study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Nijisha K 
Designation  Post Graduate Scholar 
Affiliation  Government homoeopathic medical college 
Address  Government homoeopathic medical college Karaparamba Kozhikode 673010
Government homoeopathic medical college Karaparamba Kozhikode 673010
Kozhikode
KERALA
673010
India 
Phone  7356448827  
Fax    
Email  nijiksajeevan28@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Abdul Hameed 
Designation  Professor  
Affiliation  Government homoeopathic medical college 
Address  OP- 3 Department of practice of medicine Government homoeopathic medical college Karaparamba Kozhikode 673010
OP-3 Department of practice of medicine Government homoeopathic medical college Karaparamba Kozhikode 673010
Kozhikode
KERALA
673010
India 
Phone  9447632227  
Fax    
Email  hameeddr@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Nijisha K 
Designation  PG student  
Affiliation  Government homoeopathic medical college 
Address  OP room number - 3 Department of practice of medicine Government homoeopathic medical college Karaparamba Kozhikode 673010
OP room number-3 Department of practice of medicine Government homoeopathic medical college karaparamba kozhikode 673010
Kozhikode
KERALA
673010
India 
Phone  7356448827  
Fax    
Email  nijiksajeevan28@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Dr Nijisha K 
Address  PG student Government homoeopathic medical college Karaparamba P.O Kozhikode kerala , India pin - 673010  
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nijisha K  Government homoeopathic medical college  department of practice of medicine Hospital Op practice of medicine OP - room 3
Kozhikode
KERALA 
7356448827

nijiksajeevan28@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee Government Homoeopathic Medical College Kozhikode Kerala  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E790||Hyperuricemia without signs of inflammatory arthritis and tophaceous disease, (2) ICD-10 Condition: E118||Type 2 diabetes mellitus with unspecified complications,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  homoeopathic medicine  Homoeopathic medicines for diabetes and hyperurecemia selected based on Homoeopathic principles of similarity and minimum dose then administered orally for 6 months and the outcome was assessed by fasting blood glucose level and serum uric acid level. The total study duration is for 1 year 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Patients within 30 to 80 years old.
Patient having both diabetes and hyperuricemia.
Patient with FBS greater than 150mg per dl.  
 
ExclusionCriteria 
Details  Patients with type 1 diabetes mellitus or other types of diabetes.
2. Patients with secondary causes of hyperuricemia (cancer, or use of certain
medications). .
3. Patients with severe comorbidities or complications that may interfere with the study
outcomes (e.g., end-stage renal disease, liver failure, or severe cardiovascular
disease).
4. Patients receiving systemic corticosteroid therapy or other immunosuppressive
medications.  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1. changes in fasting blood glucose level
2. changes in serum uric acid level 
1. changes in fasting blood glucose level will be checked after 6 months of giving medicines
2. changes in serum uric acid level will be checked after 6 months of giving medicines
total duration of study is 1 year 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="24"
Sample Size from India="24" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   20/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  20/07/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   A prospective clinical study will be conducted in patients attending the  outpatient sections of the Government Homoeopathic Medical College, Kozhikode. The period of study will be minimum of 1 year from date of onset of research.  A minimum of 24 cases of patients coexisting  with hyperuricemia and diabetes  satisfying the inclusion and exclusion criteria will be taken up for the study. Consent is obtained after explaining the study in detail to the individual. Blood glucose level  and serum uric acid   will be done. All cases will be treated according to the principles of Homoeopathy. Each case will be reviewed at6 months . Outcome of the treatment will be assessed by changes in blood glucose level and serum uric acid level. Final evaluation of data will be done by means of an appropriate statistical method. 
Close